Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Toyama, Taisho to Respect Each Other's Independence
September 2, 2002
- Hitachi High-Tech to Market bioMerieux's Blood Coagulation Products
September 2, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 2, 2002
- Fujirebio: Half-year Sales Down 4.8% to \12,209 Mil.
September 2, 2002
- General Hospitals' Earnings Up 3 Years in a Row: SWMSC Report
September 2, 2002
- Medical Fee Revision Favors Major Dispensing Pharmacies: Nomura Report
September 2, 2002
- 70% of Patients Don't Like Substitutive Generics: Survey
September 2, 2002
- MEDICAL DEVICE NEWS IN BRIEF
September 2, 2002
- Ivermectin, Micafungin Recommended for Approval by CDFS
September 2, 2002
- FY2003 Social Security-related Budget Request Up \691 Bil.
August 26, 2002
- OTC NEWS IN BRIEF
August 26, 2002
- MR-kun Used by 10 Companies: Mr Tanimura of So-net M3
August 26, 2002
- REGULATORY NEWS IN BRIEF
August 26, 2002
- DIAGNOSTIC NEWS IN BRIEF
August 26, 2002
- WORLD NEWS IN BRIEF
August 26, 2002
- BULLETIN -2-
August 26, 2002
- Korosho to Issue GLP for Medical Devices in September
August 26, 2002
- Taisho, Toyama Aiming at \300 Bil. Ethical Drug Sales in FY2015: Taisho President
August 26, 2002
- Kirin Develops Calves with Human Antibody Genes
August 26, 2002
- Guidant to Acquire Cook Group
August 26, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…